S&P 500 7,794.02 −0.32%
Nasdaq 27,476.98 −0.45%
S&P/TSX 35,129.49 −1.46%
Apple 334.84 +0.36%
Nvidia 237.20 −0.85%
Microsoft 528.10 −0.23%
Shopify 234.45 +0.31%
Royal Bank 274.84 −1.56%
CAD/USD 0.7015 +0.06%
LIVE · 12:15 ET
Market ClerkRecap
Wed Oct 7 · markets open4 signals today187 insider buys this week · $475.6MCIRO short report next: Oct 15The week ahead
RG
INSIDER · RDHL · RedHill Biopharma Ltd. · CHIEF OPERATING OFFICER

Raday Gilead

Every open-market transaction filed under this name, Oct 1 to Oct 1.

Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$1K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1RDHLRedHill Biopharma Ltd.Chief Operating OfficerSell14,310,000$0.00$1K+485900.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.